The ibuprofen COVID-19 paradox
With the surge of information surrounding COVID-19 released in the news this year, an interesting concern arose regarding ibuprofen’s use in patients with COVID-19. In March of 2020, French authorities were the first to investigate anecdotal reports of severe COVID-19 infection in patients who had taken ibuprofen.
The initial concern involved the ACE-2 receptor. The theoretical concern was that NSAIDs (nonsteroidal anti-inflammatory drugs) such as ibuprofen might …
The ibuprofen COVID-19 paradox
















![Finding peace and reclaiming humanity within a broken health care system [PODCAST]](https://kevinmd.com/wp-content/uploads/058307ba-bb36-43f1-9e3a-6e3100f183b5-190x100.jpeg)


![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)






